Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$71.72 - $91.47 $8,319 - $10,610
-116 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$74.77 - $85.47 $13,234 - $15,128
-177 Reduced 60.41%
116 $9,000
Q1 2021

Apr 20, 2021

SELL
$74.73 - $90.69 $6,576 - $7,980
-88 Reduced 23.1%
293 $22,000
Q4 2020

Feb 02, 2021

BUY
$72.61 - $90.2 $3,122 - $3,878
43 Added 12.72%
381 $33,000
Q3 2020

Oct 15, 2020

BUY
$71.87 - $131.03 $1,437 - $2,620
20 Added 6.29%
338 $26,000
Q2 2020

Jul 27, 2020

BUY
$79.55 - $124.22 $7,318 - $11,428
92 Added 40.71%
318 $39,000
Q1 2020

Apr 22, 2020

BUY
$71.37 - $96.85 $16,129 - $21,888
226 New
226 $19,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Evolution Wealth Advisors, LLC Portfolio

Follow Evolution Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.